Cannabis

07.09.2020 • News

Amyris Scales up Cannabinoid Process

Synthetic biotech company Amyris said it has successfully scaled up commercial production of cannabigerol (CBG) through leveraging its industrial fermentation process capability. The precursor from which all other cannabinoids are synthesized, CBG is a non-psychoactive cannabinoid that is said to present significant therapeutic potential.

Top-Feature

IMCD Deutschland GmbH

Fostering Innovation and Collaboration

Ecocool GmbH

Transport Logistic: Ecocool Presents Packaging Solutions for Pharmaceutical Transports

Evonik Industries AG

Maximize the Potential of Spent Hydroprocessing Catalysts

CHEManager International c/o Wiley-VCH GmbH

Digitalization in the Chemical Industry

Free Virtual Event

Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.